TY  - GEN
AU  - Lê,Minh P
AU  - Mandelbrot,Laurent
AU  - Descamps,Diane
AU  - Soulié,Cathia
AU  - Ichou,Houria
AU  - Bourgeois-Moine,Agnès
AU  - Damond,Florence
AU  - Lariven,Sylvie
AU  - Valantin,Marc-Antoine
AU  - Landman,Roland
AU  - Faucher,Philippe
AU  - Tubiana,Roland
AU  - Duro,Dominique
AU  - Meier,Françoise
AU  - Legac,Sylvie
AU  - Bourse,Patricia
AU  - Mortier,Emmanuel
AU  - Dommergues,Marc
AU  - Calvez,Vincent
AU  - Matheron,Sophie
AU  - Peytavin,Gilles
TI  - Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women
SN  - 2040-2058
PY  - 2016///0517
KW  - Adult
KW  - Atazanavir Sulfate
KW  - adverse effects
KW  - CD4 Lymphocyte Count
KW  - Cross-Sectional Studies
KW  - Drug Administration Schedule
KW  - Drug Combinations
KW  - Female
KW  - HIV Protease Inhibitors
KW  - HIV-1
KW  - drug effects
KW  - Humans
KW  - Hyperbilirubinemia
KW  - chemically induced
KW  - Infant, Newborn
KW  - Pregnancy
KW  - Pregnancy Complications, Infectious
KW  - drug therapy
KW  - Ritonavir
KW  - Viral Load
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3851/IMP2936
ER  -